Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Will therapies that target tumour suppressor genes be useful in cancer treatment?

Advances in clinical and experimental medicine : official organ Wroclaw Medical University - 1 Jan 2000

Szychot Elwira, Brodkiewicz Andrzej, Peregud-Pogorzelski Jarosław

Abstract excerpt

Human cancers represent one of the biggest challenges for modern societies. By 2020, cancer deaths worldwide could reach 10 million. Therefore, one of the important aims of science research is the improvement of anti-malignant treatment options to mitigate cancer-related morbidity and mortality. This essay summarises current trends and future directions of target tumour suppressor genes therapies based on an...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemoradiotherapy
Share to Genes, p53

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, Suppressor

Share to Mutation

Share to Neoplasms

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 24431316

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Will therapies that target tumour suppressor genes be useful in cancer treatment?PMID 24431316Read ↗

Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and OpportunitiesSemantic proximity Read ↗

An overview of the functions of p53 and drugs acting either on wild- or mutant-type p53.Semantic proximity Read ↗

Exploiting the p53 pathway for cancer diagnosis and therapy.Semantic proximity Read ↗

The guardian of the genome meets immunotherapy: p53-based strategies.Semantic proximity Read ↗

Cancer therapy based on p53.Semantic proximity Read ↗

Strategies for therapeutic targeting of the p53 pathway in cancer.Semantic proximity Read ↗

Methods for screening tumors for p53 status and therapeutic exploitation.Semantic proximity Read ↗

Drugging p53 in cancer: one protein, many targets.Semantic proximity Read ↗

Targeting the p53 signaling pathway in cancer therapy – the promises, challenges and perilsSemantic proximity Read ↗

The Undervalued Avenue to Reinstate Tumor Suppressor Functionality of the p53 Protein Family for Improved Cancer Therapy - Drug RepurposingSemantic proximity Read ↗

Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.Semantic proximity Read ↗

Targeting mutant p53 in cancer: from mechanistic insights to therapeutic strategies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.